These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36452509)

  • 1. Alterations in white matter fiber density associated with structural MRI and metabolic PET lesions following multimodal therapy in glioma patients.
    Friedrich M; Farrher E; Caspers S; Lohmann P; Lerche C; Stoffels G; Filss CP; Weiss Lucas C; Ruge MI; Langen KJ; Shah NJ; Fink GR; Galldiks N; Kocher M
    Front Oncol; 2022; 12():998069. PubMed ID: 36452509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the default mode resting-state network for cognitive functioning in malignant glioma patients following multimodal treatment.
    Kocher M; Jockwitz C; Caspers S; Schreiber J; Farrher E; Stoffels G; Filss C; Lohmann P; Tscherpel C; Ruge MI; Fink GR; Shah NJ; Galldiks N; Langen KJ
    Neuroimage Clin; 2020; 27():102287. PubMed ID: 32540630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of brain lesions on health-related quality of life in patients with WHO CNS grade 3 or 4 glioma: a lesion-function and resting-state fMRI analysis.
    Heinzel A; Mottaghy FM; Filss C; Stoffels G; Lohmann P; Friedrich M; Shah NJ; Caspers S; Lucas CW; Ruge MI; Galldiks N; Fink GR; Langen KJ; Kocher M
    J Neurooncol; 2023 Feb; 161(3):643-654. PubMed ID: 36750534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lesion-Function Analysis from Multimodal Imaging and Normative Brain Atlases for Prediction of Cognitive Deficits in Glioma Patients.
    Kocher M; Jockwitz C; Lohmann P; Stoffels G; Filss C; Mottaghy FM; Ruge MI; Weiss Lucas C; Goldbrunner R; Shah NJ; Fink GR; Galldiks N; Langen KJ; Caspers S
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-(2-[(18)F]fluoroethyl)-L-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy.
    Sweeney R; Polat B; Samnick S; Reiners C; Flentje M; Verburg FA
    Ann Nucl Med; 2014 Feb; 28(2):154-62. PubMed ID: 24272067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous FET-PET and contrast-enhanced MRI based on hybrid PET/MR improves delineation of tumor spatial biodistribution in gliomas: a biopsy validation study.
    Song S; Cheng Y; Ma J; Wang L; Dong C; Wei Y; Xu G; An Y; Qi Z; Lin Q; Lu J
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1458-1467. PubMed ID: 31919633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study.
    Verburg N; Koopman T; Yaqub MM; Hoekstra OS; Lammertsma AA; Barkhof F; Pouwels PJW; Reijneveld JC; Heimans JJ; Rozemuller AJM; Bruynzeel AME; Lagerwaard F; Vandertop WP; Boellaard R; Wesseling P; de Witt Hamer PC
    Neuro Oncol; 2020 Mar; 22(3):412-422. PubMed ID: 31550353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
    Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
    World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Ort J; Hamou HA; Kernbach JM; Hakvoort K; Blume C; Lohmann P; Galldiks N; Heiland DH; Mottaghy FM; Clusmann H; Neuloh G; Langen KJ; Delev D
    J Neurooncol; 2021 Oct; 155(1):71-80. PubMed ID: 34599479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioma Recurrence Versus Radiation Necrosis: Single-Session Multiparametric Approach Using Simultaneous O-(2-18F-Fluoroethyl)-L-Tyrosine PET/MRI.
    Jena A; Taneja S; Gambhir A; Mishra AK; Dʼsouza MM; Verma SM; Hazari PP; Negi P; Jhadav GK; Sogani SK
    Clin Nucl Med; 2016 May; 41(5):e228-36. PubMed ID: 26859208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of 18F-fluoroethyl-L-tyrosine PET and MRI in small nonspecific incidental brain lesions.
    Floeth FW; Sabel M; Stoffels G; Pauleit D; Hamacher K; Steiger HJ; Langen KJ
    J Nucl Med; 2008 May; 49(5):730-7. PubMed ID: 18413396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence-guidance in non-Gadolinium enhancing, but FET-PET positive gliomas.
    Schebesch KM; Brawanski A; Doenitz C; Rosengarth K; Proescholdt M; Riemenschneider MJ; Grosse J; Hellwig D; Höhne J
    Clin Neurol Neurosurg; 2018 Sep; 172():177-182. PubMed ID: 30032095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of (18)F-fluoroethyl tyrosine positron-emission tomography uptake values and histomorphological findings by stereotactic serial biopsy in newly diagnosed brain tumors using a refined software tool.
    Lopez WO; Cordeiro JG; Albicker U; Doostkam S; Nikkhah G; Kirch RD; Trippel M; Reithmeier T
    Onco Targets Ther; 2015; 8():3803-15. PubMed ID: 26719708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Biopsy-Controlled Prospective Study of Contrast-Enhancing Diffuse Glioma Infiltration Based on FET-PET and FLAIR.
    Harat M; Miechowicz I; Rakowska J; Zarębska I; Małkowski B
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.
    Fujii Y; Muragaki Y; Maruyama T; Nitta M; Saito T; Ikuta S; Iseki H; Hongo K; Kawamata T
    J Neurosurg; 2018 Jul; 129(1):1-9. PubMed ID: 28885120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial Relationship of Glioma Volume Derived from
    Mauler J; Maudsley AA; Langen KJ; Nikoubashman O; Stoffels G; Sheriff S; Lohmann P; Filss C; Galldiks N; Kops ER; Shah NJ
    J Nucl Med; 2018 Apr; 59(4):603-609. PubMed ID: 28848036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction of a standardized multimodality image protocol for navigation-guided surgery of suspected low-grade gliomas.
    Mert A; Kiesel B; Wöhrer A; Martínez-Moreno M; Minchev G; Furtner J; Knosp E; Wolfsberger S; Widhalm G
    Neurosurg Focus; 2015 Jan; 38(1):E4. PubMed ID: 25552284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas.
    Gross MW; Weber WA; Feldmann HJ; Bartenstein P; Schwaiger M; Molls M
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):989-95. PubMed ID: 9719107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Static FET-PET and MR Imaging in Anaplastic Gliomas (WHO III).
    Bette S; Peschke P; Kaesmacher J; Delbridge C; Pyka T; Schmidt-Graf F; Zimmer C; Meyer B; Ringel F; Gempt J
    World Neurosurg; 2016 Jul; 91():524-531.e1. PubMed ID: 26947726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential for differentiation of glioma recurrence from radionecrosis using integrated
    Sogani SK; Jena A; Taneja S; Gambhir A; Mishra AK; D'Souza MM; Verma SM; Hazari PP; Negi P; Jadhav GK
    Neurol India; 2017; 65(2):293-301. PubMed ID: 28290392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.